Infographic: Efficacy and safety of high-dose Intravitreal aflibercept 8 mg in patients with neovascular age-related macular degeneration: week 48 results from the phase 3 PULSAR trial. - Heier JS; Zhang X; Reed K; Berliner A; Leal S (Eye (London, England), 2025)